首页> 外文期刊>Acta Pharmaceutica Sinica B >Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery
【24h】

Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery

机译:达功能化的Ag-Fe3O4纳米复合材料,可作为穿透组织的载体用于肿瘤磁靶向和药物递送

获取原文
           

摘要

In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-Fe3O4 nanocomposites (Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC50 of Tat-FeAgNP-Dox to be 0.63?μmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% ( P = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles.
机译:在本文中,我们基于糊精包被的银纳米颗粒制备了双功能系统,该纳米颗粒进一步与氧化铁纳米颗粒和细胞穿透肽(Tat)结合,产生了Tat修饰的Ag-Fe3O4纳米复合材料(Tat-FeAgNPs)。为了装载药物,设计并合成了含–SH的连接基3-巯基丙酰肼。它使银载体能够以pH敏感模式加载和释放阿霉素(Dox)。使用MCF-7细胞在体外评估该系统的递送效率,并使用携带MCF-7异种移植肿瘤的无效BalB / c小鼠体内评估该系统的递送效率。我们的研究结果表明,Tat和外部施加的磁场均可促进细胞吸收,从而促进阿霉素纳米颗粒的细胞毒性,Tat-FeAgNP-Dox的IC50为0.63?μmol/ L。使用体内光学成像测试分析了携带Cy5的Tat-FeAgNP向小鼠肿瘤的体内递送效率,其中Tat-FeAgNP-Cy5在肿瘤中产生了最有效的积累(Tat-FeAgNP的ID为6.7±2.4% )。抗肿瘤评估还表明,Tat-FeAgNP-Dox表现出最显着的抑瘤作用,并将肿瘤的比生长速率降低了29.6%(P = 0.009),这可以归因于其在肿瘤药物递送中的优越性能。与对照纳米车辆的比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号